A person must also be at least 18 years old and meet one of the following criteria: Have a body mass index (BMI) of at least 35 at the time they begin the GLP-1 medication Have a BMI of at least 30 at the time of beginning the medication and at least one of the following diagnoses: Heart failure with preserved ejection fraction Uncontrolled hypertension Chronic kidney disease (stage 3a or above) Have a BMI of at least 27 at the time of beginning the medication and at least one of the following diagnoses: Pre-diabetes Previous heart attack Previous stroke Symptomatic peripheral artery disease Anyone who meets these qualifications but is eligible to receive GLP-1 coverage under Part D for another condition, like type 2 diabetes, wont qualify for the Bridge program, CMS says
(2) ALK brand 10ml sealed, empty vials
Cusi et al., 2018)
The headline claims LifeVantage reports the following results from their clinical research: 200%+ average increase in GLP-1 levels Average weight loss of 11 pounds in 12 weeks, with some participants losing up to 25 pounds 100% of participants who lost weight maintained muscle mass Up to 6% total body fat percentage lost Up to 24% visceral fat reduction 86% decreased food, salt, and soda cravings 95% decreased sugar cravings 89% decreased fast food cravings These numbers look impressive at first glance
Better Absorption Since the nutrients go straight into your bloodstream, your body gets the full benefitno loss through digestion
The total amount of protein was determined using a BCA protein assay kit (Beyotime, Shanghai, China)
